| 0 (0%) | 11-11 21:05 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 60.81 | 1-year : | 71.03 |
| Resists | First : | 52.06 | Second : | 60.81 |
| Pivot price | 51.39 |
|||
| Supports | First : | 48.96 | Second : | 47.04 |
| MAs | MA(5) : | 51.36 | MA(20) : | 50.94 |
| MA(100) : | 50.89 |
MA(250) : | 51.27 |
|
| MACD | MACD : | 0.3  |
Signal : | 0.3 |
| %K %D | K(14,3) : | 69.4 |
D(3) : | 72.1 |
| RSI | RSI(14): 60.2 | |||
| 52-week | High : | 54.72 | Low : | 47.04 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ DTP ] has closed above bottom band by 43.3%. Bollinger Bands are 80.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 52.19 - 52.45 | 52.45 - 52.66 |
| Low: | 50.17 - 50.52 | 50.52 - 50.8 |
| Close: | 50.88 - 51.41 | 51.41 - 51.84 |
Fri, 07 Nov 2025
Convergence of DTP, DTC, and DTE Models Expected to Increase Role of Pharmaceutical Sales Representatives - geneonline.com
Fri, 07 Nov 2025
NorthWest Biosciences (NWB) DTP – Blind Recruitment for Inclusive PhD Admissions - Lancaster University
Thu, 06 Nov 2025
Direct-to-Patient (DTP): Who Benefits - and Why It’s Different - Pharmaceutical Commerce
Thu, 06 Nov 2025
The New Pharma Equation: How DTP, DTC, and DTE are Re-Wiring Healthcare Around Patients - Pharmaceutical Commerce
Wed, 29 Oct 2025
Denver Men’s Tennis Set to Host Colorado Cup at DTP - University of Denver Athletics
Tue, 28 Oct 2025
Novartis CEO Says Company Might Expand DTP Sales in U.S. - NAVLIN DAILY
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | 2022-01-31 |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|